Sök artiklar i SveMed+

Observera: SveMed+ upphör att uppdateras!



Utvikling av Churg-Strauss' syndrom etter bruk av Singulair (montelukast)
Engelsk titel: Churg-Strauss syndrome after treatment with Singulair (montelukast) Läs online Författare: Hammer HB ; Aukrust P ; Fröland SS Språk: Nor Antal referenser: 14 Dokumenttyp: Fallbeskrivning UI-nummer: 02031951

Tidskrift

Tidsskrift for Den Norske Laegeforening 2002;122(5)484-6 ISSN 0029-2001 E-ISSN 0807-7096 KIBs bestånd av denna tidskrift Denna tidskrift är expertgranskad (Peer-Reviewed)

Sammanfattning

INTERPRETATION : To our knowledge, this is the first report in a Nordic country of an association between montelukast and Churg-Strauss syndrome. Although this is a rare association, the clinicians need to be vigilant in all patients who develop systemic symptoms when starting treatment with leukotriene antagonists. MATERIAL AND METHODS : This is a case report of the appearance of Churg-Strauss syndrome in a 20-year-old asthmatic woman treated with montelukast and with no recent oral corticosteroid use. BACKGROUND : Montelukast is the only available antileukotriene drug in Norway. It works against the inflammation, bronchospasm and airway oedema caused by leukotrienes. In the literature there are some reports on an association between the use of the leukotriene antagonists zafirlukast, pranlukast, montelukast and the appearance of Churg-Strauss syndrome. This rare syndrome is a systemic vasculitis characterized by allergic rhinitis, asthma and prominent peripheral blood eosinophilia.